The MicrofluidX technology platform is a revolutionary platform for cell and gene therapy manufacturing. Our key objectives are to reduce production cost by 60-90%, reduce investment costs for new production facilities by 50-70%, enable virtually infinite process scalability through the pre-clinical, clinical and commercial phases of the therapeutic development and increase final product quality and stability.
Location: United Kingdom, England, London
Member count: 11-50
Total raised: $4.015898M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Cambridge ... | cambridgea... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 08.12.2022 | - | $4.015898M | - | cambridgea... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 08.12.2022 | Microfluid... | - | - | - | cambridgea... |
| - | Microfluid... | “At MicrofluidX, we are tackli... | - | - | fastfounde... |